Everything below concerns REV-ERB agonist. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2026-01-07. Numbers and descriptions here follow the published literature rather than marketing material.
Identity and purity of SR9009 samples are usually checked with chromatographic and spectrometric methods. High-performance liquid chromatography can separate the compound from related impurities, while mass spectrometry provides molecular mass confirmation. Nuclear magnetic resonance spectroscopy may be used for structural verification in research settings. No single method proves biological activity, and certificates of analysis should be reviewed alongside raw data. Independent testing is often needed because online products vary widely.
SR9009 stability depends on temperature, moisture, light, and solvent. Solid material is generally kept cool and dry, while solutions may require protection from repeated warming and cooling. Degradation can appear as color changes, precipitate, or new chromatographic peaks. Researchers should follow supplier instructions and their own stability data. Long-term storage conditions for human use have not been established because the compound lacks approved clinical formulation.
SR9009 is supplied as a solid research chemical, often in milligram quantities. Laboratories typically weigh it in a controlled environment because fine powders can disperse. Stock solutions are commonly prepared in dimethyl sulfoxide and stored in small aliquots to reduce freeze-thaw cycles. Personal protective equipment and chemical fume hoods are standard when handling unknown or potent compounds. These practices address laboratory safety rather than human use.
Several misconceptions surround SR9009. It is often described as a SARM, a steroid, or an exercise pill, but its known target is the REV-ERB receptor family. Rodent studies have examined exercise capacity and metabolic markers, yet human outcomes remain unproven. Oral bioavailability appears low in animals, and human pharmacokinetics are not well characterized. Online products may contain impurities or different compounds, so identity and purity testing are important for research use.
Analytical chemists detect SR9009 with liquid chromatography-tandem mass spectrometry, commonly abbreviated LC-MS/MS. Sample preparation may involve protein precipitation, liquid-liquid extraction, or solid-phase extraction before analysis. Laboratories can target the parent compound or its metabolites, depending on the matrix and the purpose of testing. Anti-doping methods require sensitive and specific assays because concentrations in biological samples can be low. Reference standards and validated methods are essential for reliable identification and quantification.
| Property | Value | Notes |
|---|---|---|
| Synonyms | SR9009; Stenabolic | Stenabolic is an informal name |
| Common form | Crystalline powder | Supplied in milligram to gram quantities |
| Long-term storage | -20 °C, desiccated, protected from light | Reduces degradation |
| Detection technique | LC-MS/MS | Common in anti-doping and research analysis |
| Regulatory status | Prohibited in sport by WADA | Not approved for human therapeutic use |
Regulatory treatment of SR9009 varies by country and context. It is not approved as a therapeutic drug by agencies such as the United States Food and Drug Administration or the European Medicines Agency. Sports authorities list it as a prohibited substance; the World Anti-Doping Agency classifies it among hormone and metabolic modulators. Legal status for personal possession or sale differs across jurisdictions, and some countries may restrict it under analog or research chemical laws. Buyers who seek verified material often rely on independent laboratory testing because online product labels may not match contents.
Laboratory samples of SR9009 are typically handled as research chemicals rather than pharmaceuticals. Suppliers usually state that the material is for research use only and not for human or veterinary administration. Storage recommendations generally call for a freezer at approximately −20 °C, protection from light, and a desiccated environment. The solid is often described as a white to off-white powder. Solubility is commonly reported in organic solvents such as dimethyl sulfoxide and ethanol, with low solubility in water.
Pharmacokinetic data for SR9009 are limited in published literature. Some reports indicate low oral bioavailability and rapid clearance in animals, which complicates interpretation of exposure and effect. Researchers often use injected routes in preclinical work to achieve measurable systemic levels. Analytical studies rely on mass spectrometry to detect the parent compound and its metabolites. Questions about tissue distribution, active metabolites, and long-term consequences remain open. Species differences in metabolism can affect observed half-life and target engagement.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms and metabolic gene expression. In laboratory experiments, SR9009 binds these receptors and alters transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. It is not a naturally occurring compound and has no approved therapeutic use. Research interest stems from its ability to modify energy metabolism in cells and animal models.
In rodent studies, SR9009 has been reported to increase mitochondrial content in skeletal muscle and improve exercise endurance under some conditions. These findings led to popular descriptions such as an exercise mimetic, although that term oversimplifies the biology. Effects vary by dose, timing, tissue, and model. The compound's influence on circadian pathways means that time of administration can matter in experiments. Whether similar metabolic changes occur in humans remains largely unexplored in controlled published trials.
REV-ERB proteins typically suppress gene expression by recruiting corepressor complexes to DNA response elements. SR9009 binds these receptors and strengthens that repressive action in cell-based assays. Studies in rodents have reported changes in lipid handling, mitochondrial function, and exercise capacity after treatment. Such findings are often cited as evidence for metabolic effects, but species differences and limited pharmacokinetic data make direct translation to humans uncertain. Researchers continue to examine which effects are robust and which depend on specific experimental conditions.
SR9009 is frequently discussed alongside other REV-ERB ligands, including synthetic agonists and natural heme-related molecules. Its selectivity for REV-ERB over related nuclear receptors has been measured in binding and reporter assays, though off-target activity at higher concentrations is possible. The compound is prohibited in sport by the World Anti-Doping Agency, and it is not approved for any medical use in major jurisdictions. Products sold online may be labeled as research chemicals, and their identity and purity are not guaranteed by regulatory review.
SR9009 is a synthetic small molecule that acts on the nuclear receptors REV-ERBα and REV-ERBβ. These receptors are part of the circadian clock machinery and normally repress transcription of certain target genes. In laboratory research, SR9009 is used as a chemical tool to study how REV-ERB activity influences metabolism, inflammation, and daily biological rhythms. The compound is not an approved medicine, and its effects in humans remain largely uncharacterized. It is often described as an investigational agent rather than a therapeutic product.
Handling recommendations for SR9009 in a laboratory setting include storing the solid at low temperature, protected from light and moisture. The compound is often dissolved in dimethyl sulfoxide or ethanol for experiments. Solutions should be prepared with appropriate personal protective equipment and disposed of according to local rules. Stability data for long-term storage are limited, so stock solutions are typically kept cold and used within defined periods. Records of preparation date and concentration support reproducibility.
SR9009 is not approved as a medicine by major regulatory agencies. It is commonly sold as a research chemical, a category that may fall outside customary drug approval and quality rules. In sports, the World Anti-Doping Agency lists SR9009 as a prohibited substance. Athletes who use it can face sanctions if it is detected in a sample. Legal status varies by country, and importation may be restricted. Enforcement practices differ across borders.
=== Synthesis === It is synthesized in two chemical steps starting from the phenone 3'-chloro-propiophenone. The alpha position adjacent to the ketone group is first brominated followed by nucleophilic displacement of the bromine atom of the resulting alpha-bromoketone group with t-butylamine and then treatment with hydrochloric acid to give bupropion as the hydrochloride salt in 75–85% overall yield.
Once the relative volume occupied by PMN cells at the junctional epithelium reaches 60%, the junctional epithelium is unable to adhere to the root surface of the tooth and separates from it while the apical portion of the junctional epithelium migrates apically. This process, known as apical migration, results in the increase of the sulcular epithelium lining of this ‘false pocket’ (pseudopocket).
Some scientists say loxapine is a "mid-potency" typical antipsychotic. However, unlike most other typical antipsychotics, it has significant potency at the 5-HT2A receptor (6.6 nM), which is similar to atypical antipsychotics like clozapine (5.35 nM). The higher likelihood of EPS with loxapine, compared to clozapine, may be due to its higher affinity for the dopamine D2 receptor (11 nM) compared to clozapine, which has one of the lowest binding affinities at the D2 receptor of any antipsychotic. Nevertheless, its higher affinity for 5-HT2A receptors over any of the dopamine receptors (54 nM for D1, 11 nM for D2, 19 nM for D3, 8.4 nM for D4 and 75 nM) makes it belong to atypical antipsychotic. On top of being an atypical antipsychotic, Amoxapine, one of the major metabolites of Loxapine, is a tricyclic antidepressant on its own right (though sometimes classified as tetracyclic antidepressant). It acts as Serotonin–norepinephrine reuptake inhibitor, and acts as moderate and strong reuptake inhibitor for Serotonin and Norepinephrine respectively. It also share with Loxapine an high affinity for 5-HT2 receptors, (0.5 nM, and 2.0 nM for 5-HT2A and 5-HT2C receptors respectively), while having lower affinity for D2 receptors (3.6 nm), retaining Loxapine's atypical antipsychotic properties. It has also significant binding affinity for 5-HT6 and 5-HT7 receptors, and Alpha-1 adrenergic receptor.
The Chinese Physical Society (CPS) is a professional society of physicists established in 1932. It is part of the China Association for Science and Technology. Current membership is at around 40,000. CPS has been a member of the International Union of Pure and Applied Physics (IUPAP) since 1984 and of the Association of Asia Pacific Physical Societies (AAPPS) since 1990.
In the mid-2010s, Valve began experimenting with virtual reality (VR). They built prototypes using their various intellectual properties such as Portal, and found that Half-Life best suited VR. Their flagship VR game, Half-Life: Alyx, entered production using Valve's new Source 2 engine in 2016, with the largest team in Valve's history, including members of Campo Santo, a studio Valve acquired in 2018.
Sources: en.wikipedia.org
=== Pregnancy === Valproate is a teratogen. Teratogens can cause birth defects. Valproate is restricted for all women under age 55 in the United Kingdom and European Union. It has a black box warning for pregnancy in the United States. There are also restrictions for men. Children fathered by men taking valproate have a higher risk of neurodevelopmental disorders. Valproate is restricted for men under age 55 in the United Kingdom and European Union. The restrictions require two specialists to agree that there is no other effective or tolerated treatment for the patient.
In September 2022, the ministry reported: "Repair work on the Cinesphere, pods, and bridges is proceeding on schedule this fall. Site servicing, including sewage, water, electrical, and gas, is expected to begin in the spring of 2023." Therme Canada's local partners are the Toronto International Film Festival (TIFF), Mississaugas of the Credit First Nation, and Black North Initiative. TIFF later 'paused' their relationship with Therme ahead of their 2023 festival. Other partners include AECON Group Inc., Diamond Schmitt, and Studio TLA. Strategy Corp is serving Therme Canada with strategy and communications. Swim Drink Fish Canada was a partner, but exited the partnership in the belief that the government's portion of the plan is "simply too opaque and controversial for us to support". Therme's plans have received strong public backlash, with the group Ontario Place for All leading the campaign against the development. Plans to develop the public space and existing beach by a for-profit private developer became a prominent 2023 election issue in Toronto. The mayoral campaign saw mayor Olivia Chow come out in opposition to the project. Later in 2023, she dropped her opposition to the project when the City and Government of Ontario reached an agreement for the transfer of the two Toronto freeways (Don Valley and Gardiner) to the province, saving the city an estimated $1.2 billion. The community group has continued its opposition, attempting to stop or slow down the project in the courts.
== Products and services == GeneDx offers genetic testing services with a primary focus on whole genome sequencing (WGS) and whole exome sequencing (WES). WGS provides a comprehensive analysis of an individual's entire genome, while WES focuses on protein-coding regions called exons, which contain a majority of known disease-related genetic variants. The company's tests are used in clinical diagnostics, research, and precision medicine by geneticists, genetic counselors, neonatologists, pediatric specialists, and pediatricians. GeneDx offers testing for conditions including rare diseases, autism spectrum disorders, epilepsy, neurodevelopmental disorders, cardiomyopathies, and inherited conditions affecting vision, the immune system, muscles, hearing, metabolism, neurology, and mitochondrial diseases. GeneDx also offers rapid sequencing options intended for critically ill pediatric and neonatal patients where timely results may influence acute medical management. GeneDx continues to develop genetic testing technologies and expand access to genomic information for clinical use in pediatric, adult, and newborn populations. Professional guidelines from organizations such as the American College of Medical Genetics and Genomics (ACMG) and the American Academy of Pediatrics (AAP) support the use of exome or genome sequencing as first-line or early diagnostic tests in selected patient populations.
== Quadrupole time-of-flight == Quadrupole time-of-flight mass spectrometry (QToF-MS) has a similar configuration to a tandem mass spectrometer with a mass-resolving quadrupole and collision cell hexapole, but instead of a second mass-resolving quadrupole, a time-of-flight mass analyzer is used. Both quadrupoles can operate in RF mode only to allow all ions to pass through to the mass analyzer with minimal fragmentation. To increase spectral detail, the system takes advantage of collision-induced dissociation. Once the ions reach the flight tube, the ion pulser sends them upwards towards the reflectron and back down into the detector. Since the ion pulser transfers the same kinetic energy to all molecules, the flight time is dictated by the mass of the analyte. QToF is capable of measuring mass to the 4th decimal place and is frequently used for pharmaceutical and toxicological analysis as a screening method for drug analogues. Identification is done by collection of the mass spectrum and comparison to tandem mass spectrum libraries.
Ancient Iranians were among the first to invent a form of cooler utilizing the principles of evaporative cooling and radiative cooling called yakhchāls. These complexes used subterranean storage spaces, a large thickly insulated above-ground domed structure, and outfitted with badgirs (wind-catchers) and series of qanats (aqueducts). Pre-electric refrigeration In modern times, before the invention of the modern electric refrigerator, icehouses and iceboxes were used to provide cool storage for most of the year. Placed near freshwater lakes or packed with snow and ice during the winter, they were once very common. Natural means are still used to cool foods today. On mountainsides, runoff from melting snow is a convenient way to cool drinks, and during the winter one can keep milk fresh much longer just by keeping it outdoors. The word "refrigeratory" was used at least as early as the 17th century.
Sources: en.wikipedia.org
== Premise == Set in Plainfield, Indiana, the series follows Ms. Pat's fictional family, the Carsons: Pat (Ms. Pat); her husband Terry (J. Bernard Calloway); her sister Denise (Tami Roman); and Pat's children Ashley (Brittany Inge); Brandon (Vince Swann); Janelle (Briyana Guadalupe); and Junebug (Theodore John Barnes). Pat sometimes struggles to adjust with the changing times and ways of her conservative Indiana town after moving there from her Atlanta, Georgia, hometown. Although blunt and sometimes hardheaded, Pat loves her family and her open-mindedness helps her succeed as a Black woman in a suburban white neighborhood.
== External links == Army Regulation 611-1: Military Occupational Classification Structure Development and Implementation (December 2022). US Army MOS Titles & Codes, Enlisted Personnel, 15 November 1950 - Korean War-era list from Korean War Educator Foundation
==== Precursor scan ==== When utilizing a precursor scan, a certain product ion is selected in Q3, and the precursor masses are scanned in Q1. This method is selective for ions having a particular functional group (e.g., a phenyl group) released by the fragmentation in q2.
The conservation of genetic material with the intention of conserving a breed. The conservation of genetic material is not limited to non-humans. Many services provide genetic storage or the preservation of stem cells at birth. They may be used to study the generation of cell lines or for stem-cell therapy.
== Public reception == The discovery of Lindow Man in 1984 at Lindow Moss in Cheshire, England, received worldwide news coverage. Newspapers adopted the nickname "Pete Marsh", while scientists investigating his remains called him Lindow Man. In April 1985, a documentary about the investigation in the BBC television series Q.E.D. was watched by more than 10 million people. His first temporary exhibition at Manchester Museum in 1987 attracted up to 2,000 visitors a day. During the exhibition, local resident Barbara O'Brien led a campaign for his remains to stay permanently in North West England. The campaign gained support from local members of Parliament and attracted coverage in local and national newspapers. In November 1987, pupils at Lindow Primary School recorded O'Brien's song, "Lindow Man We Want You Back Again". The campaign was unsuccessful, and the British Museum retained the remains. The Manchester Museum exhibition of 2008–2009 presented different perspectives on Lindow Man through personal accounts from people involved in his discovery and study, museum curators, a local resident and a pagan contributor. According to museum curator Bryan Sitch, public responses were mixed but broadly favourable. Some visitors questioned the inclusion of a pagan viewpoint alongside scientific interpretations, while others criticised the design or wanted more factual information. Visitors left thousands of comment cards and personal offerings, which the museum collected for further study. The exhibition also contributed to debate about whether human remains should be displayed.
Sources: en.wikipedia.org
Laboratories commonly use liquid chromatography coupled with mass spectrometry to detect SR9009. The method can identify the compound and estimate concentration in a sample. Detection limits depend on the matrix and instrument.
Research-grade purity indicates a supplier's measured percentage of the intended compound. It does not guarantee safety, sterility, or suitability for human consumption. Buyers should request a certificate of analysis with chromatograms and test methods.
Sports regulators prohibit SR9009 because it is a non-approved substance with potential performance-altering effects. Its presence can be detected in anti-doping testing. Athletes are responsible for substances found in their samples.
Legality depends on the country and the intended use. In many places it is not approved as a medicine and may be sold only as a research chemical. Importation or possession can be restricted, and sports organizations prohibit it.